JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,668,039 | -52.6% | 5,106,341 | 0.0% | 0.12% | -57.8% |
| Q3 2022 | $11,949,000 | -9.5% | 5,106,341 | +17.2% | 0.28% | -19.4% |
| Q2 2022 | $13,206,000 | -58.4% | 4,358,433 | -6.9% | 0.34% | -48.2% |
| Q1 2022 | $31,780,000 | +32.9% | 4,680,412 | +63.5% | 0.66% | +88.5% |
| Q4 2021 | $23,908,000 | +130.5% | 2,863,198 | +105.1% | 0.35% | +123.7% |
| Q3 2021 | $10,374,000 | – | 1,396,203 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |